Recent Sentinel Activity
This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.
Loading...
| Recent Activity | ||||
|---|---|---|---|---|
| https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation | COVID-19 Pregnancy Study Implementation | Methods, Data, & Tools | 02/24/2021 | COVID-19 Pregnancy Study ImplementationMethods, Data, & Tools 02/24/2021 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table | Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis | Modular Programs | 03/11/2021 | Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive AnalysisModular Programs 03/11/2021 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/venous-and-arterial-thromboembolism-among-new-users-nuvaring | Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis | Modular Programs | 03/25/2021 | Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive AnalysisModular Programs 03/25/2021 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/lymphoma-risk-following-guselkumab-risankizumab-or | Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis | Modular Programs | 03/30/2021 | Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive AnalysisModular Programs 03/30/2021 |
| https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/adbry-tralokinumab | Assessment of ARIA Sufficiency: Adbry (tralokinumab) | Sufficiency Assessments | 04/08/2021 | Assessment of ARIA Sufficiency: Adbry (tralokinumab)Sufficiency Assessments 04/08/2021 |
| https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/dayvigo-lemborexant | Assessment of ARIA Sufficiency: Dayvigo (lemborexant) | Sufficiency Assessments | 04/08/2021 | Assessment of ARIA Sufficiency: Dayvigo (lemborexant)Sufficiency Assessments 04/08/2021 |
| https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/gimoti-metoclopramide-nasal-spray | Assessment of ARIA Sufficiency: Gimoti (metoclopramide nasal spray) | Sufficiency Assessments | 04/08/2021 | Assessment of ARIA Sufficiency: Gimoti (metoclopramide nasal spray)Sufficiency Assessments 04/08/2021 |
| https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/leqvio-inclisiran | Assessment of ARIA Sufficiency: Leqvio (inclisiran) | Sufficiency Assessments | 04/08/2021 | Assessment of ARIA Sufficiency: Leqvio (inclisiran)Sufficiency Assessments 04/08/2021 |
| https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/opzelura-ruxolitinib | Assessment of ARIA Sufficiency: Opzelura (ruxolitinib) | Sufficiency Assessments | 04/08/2021 | Assessment of ARIA Sufficiency: Opzelura (ruxolitinib)Sufficiency Assessments 04/08/2021 |
| https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/qulipta-atogepant | Assessment of ARIA Sufficiency: Qulipta (atogepant) | Sufficiency Assessments | 04/08/2021 | Assessment of ARIA Sufficiency: Qulipta (atogepant)Sufficiency Assessments 04/08/2021 |
| https://sentinelinitiative.org/news-events/publications-presentations/utilization-hydroxyprogesterone-caproate-among-pregnancies | Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database | Publications and Presentations | 04/29/2021 | Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed DatabasePublications and Presentations 04/29/2021 |
| https://sentinelinitiative.org/methods-data-tools/methods/treescan-pregnancy | TreeScan in Pregnancy | Methods, Data, & Tools | 07/14/2021 | TreeScan in PregnancyMethods, Data, & Tools 07/14/2021 |
| https://sentinelinitiative.org/news-events/publications-presentations/use-mobile-app-capture-supplemental-health-information-0 | Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research | Publications and Presentations | 08/23/2021 | Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical ResearchPublications and Presentations 08/23/2021 |
| https://sentinelinitiative.org/news-events/publications-presentations/no-differential-risk-cutaneous-small-vessel-vasculitis-oral | No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation | Publications and Presentations | 08/24/2021 | No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial FibrillationPublications and Presentations 08/24/2021 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-multiple-sclerosis-drugs-among-pregnant-women-live-birth | Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis | Assessments | 10/20/2021 | Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive AnalysisAssessments 10/20/2021 |
| https://sentinelinitiative.org/news-events/publications-presentations/reliable-insights-regarding-medication-outcomes-real-world | Reliable Insights Regarding Medication Outcomes From Real World Data – Key Principles of an Evidence Generation Framework | Publications and Presentations | 11/01/2021 | Reliable Insights Regarding Medication Outcomes From Real World Data – Key Principles of an Evidence Generation FrameworkPublications and Presentations 11/01/2021 |
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-community-building-and-outreach-center | 2022 Sentinel Community Building and Outreach Center Webinar Series | Sentinel Initiative Events | 11/23/2021 | 2022 Sentinel Community Building and Outreach Center Webinar SeriesSentinel Initiative Events 11/23/2021 |
| https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/data-quality-review-and-characterization-programs | Data Quality Review and Characterization Programs | Methods, Data, & Tools | 12/16/2021 | Data Quality Review and Characterization ProgramsMethods, Data, & Tools 12/16/2021 |
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-and-methods-seminar-series | 2022 Sentinel Innovation and Methods Seminar Series | Sentinel Initiative Events | 01/01/2022 | 2022 Sentinel Innovation and Methods Seminar SeriesSentinel Initiative Events 01/01/2022 |
| https://sentinelinitiative.org/methods-data-tools/methods/improving-capture-race-and-ethnicity-data-sentinel | Improving Capture of Race and Ethnicity Data in Sentinel | Methods, Data, & Tools | 03/08/2022 | Improving Capture of Race and Ethnicity Data in SentinelMethods, Data, & Tools 03/08/2022 |
| https://sentinelinitiative.org/methods-data-tools/methods/sentinel-innovation-center-request-proposal-feature-engineering | Sentinel Innovation Center Request for Proposal: Feature Engineering | Methods, Data, & Tools | 03/15/2022 | Sentinel Innovation Center Request for Proposal: Feature EngineeringMethods, Data, & Tools 03/15/2022 |
| https://sentinelinitiative.org/engage-sentinel/quarterly-newsletter | Quarterly Newsletter | Spotlight | 03/24/2022 | Quarterly NewsletterSpotlight 03/24/2022 |
| https://sentinelinitiative.org/methods-data-tools/software-packages-toolkits/sentinel-views | Sentinel Views | 04/22/2022 | Sentinel Views04/22/2022 |
|
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/can-we-train-machine-learning-methods-outperform-high | Can We Train Machine Learning Methods to Outperform the High-Dimensional Propensity Score Algorithm? | Sentinel Initiative Events | 05/11/2022 | Can We Train Machine Learning Methods to Outperform the High-Dimensional Propensity Score Algorithm?Sentinel Initiative Events 05/11/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/serious-infection-following-ustekinumab-use-patients-crohn-s | Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease or Ulcerative Colitis: A Descriptive Analysis | Analyses | 05/17/2022 | Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease or Ulcerative Colitis: A Descriptive AnalysisAnalyses 05/17/2022 |
| https://sentinelinitiative.org/news-events/publications-presentations/scalable-algorithm-development-alternative-algorithm-reuse | Scalable Algorithm Development: An Alternative to Algorithm Reuse? | Publications and Presentations | 05/17/2022 | Scalable Algorithm Development: An Alternative to Algorithm Reuse?Publications and Presentations 05/17/2022 |
| https://sentinelinitiative.org/studies/drugs/makena-hydroxyprogesterone-caproate-injection-and-its-generics | Makena (Hydroxyprogesterone Caproate Injection) and Its Generics & Use in Pregnancy | Studies | 05/31/2022 | Makena (Hydroxyprogesterone Caproate Injection) and Its Generics & Use in PregnancyStudies 05/31/2022 |
| https://sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health | Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes | Methods, Data, & Tools | 06/01/2022 | Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication OutcomesMethods, Data, & Tools 06/01/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outpatient-corticosteroid-use-patients-covid-19-descriptive | Outpatient Corticosteroid Use in Patients With COVID-19: A Descriptive Analysis | Analyses | 06/01/2022 | Outpatient Corticosteroid Use in Patients With COVID-19: A Descriptive AnalysisAnalyses 06/01/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outpatient-corticosteroid-use-patients-covid-19-updated | Outpatient Corticosteroid Use in Patients With COVID-19: An Updated Descriptive Analysis | Analyses | 06/02/2022 | Outpatient Corticosteroid Use in Patients With COVID-19: An Updated Descriptive AnalysisAnalyses 06/02/2022 |
| https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-data-model | Sentinel Common Data Model | Methods, Data, & Tools | 06/03/2022 | Sentinel Common Data ModelMethods, Data, & Tools 06/03/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/bamlanivimab-bamlanivimab-and-etesevimab-and-casirivimab | Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis | Analyses | 06/14/2022 | Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive AnalysisAnalyses 06/14/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterizing-pregnant-women-and-without-evidence-heart | Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis | Analyses | 06/21/2022 | Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched AnalysisAnalyses 06/21/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/count-and-duration-follow-new-onset-cancer-updated | Count and Duration of Follow up of New-Onset Cancer: An Updated Descriptive Analysis | Analyses | 06/23/2022 | Count and Duration of Follow up of New-Onset Cancer: An Updated Descriptive AnalysisAnalyses 06/23/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/tacrolimus-use-patients-following-liver-or-kidney | Tacrolimus Use in Patients Following Liver or Kidney Transplants: A Descriptive Analysis | Analyses | 06/24/2022 | Tacrolimus Use in Patients Following Liver or Kidney Transplants: A Descriptive AnalysisAnalyses 06/24/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use | Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis | Analyses | 06/24/2022 | Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive AnalysisAnalyses 06/24/2022 |
| https://sentinelinitiative.org/news-events/publications-presentations/surveillance-adverse-infant-outcomes-following-maternal | Surveillance of Adverse Infant Outcomes Following Maternal Medication Use During Pregnancy Using Tree-Based Scan Statistics | Publications and Presentations | 06/28/2022 | Surveillance of Adverse Infant Outcomes Following Maternal Medication Use During Pregnancy Using Tree-Based Scan StatisticsPublications and Presentations 06/28/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/comparative-effectiveness-azithromycin-relative-roflumilast | Comparative Effectiveness of Azithromycin Relative to Roflumilast in Individuals With Uncontrolled Chronic Obstructive Pulmonary Disease Despite Triple Inhaled Therapy | Assessments | 06/28/2022 | Comparative Effectiveness of Azithromycin Relative to Roflumilast in Individuals With Uncontrolled Chronic Obstructive Pulmonary Disease Despite Triple Inhaled TherapyAssessments 06/28/2022 |
| https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/seizure-algorithm-defined-seizures-following-gadolinium | Seizure Algorithm Defined in "Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis" | Methods, Data, & Tools | 06/29/2022 | Seizure Algorithm Defined in "Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis"Methods, Data, & Tools 06/29/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/seizures-following-gadolinium-based-contrast-agents-exposure | Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis | Analyses | 06/29/2022 | Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval AnalysisAnalyses 06/29/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table | Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis | Analyses | 06/30/2022 | Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive AnalysisAnalyses 06/30/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-sodium-glucose-co-transporter-2-sglt-2-inhibitor | Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis | Analyses | 07/11/2022 | Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive AnalysisAnalyses 07/11/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hospitalization-and-anaphylaxis-following-monoclonal | Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis | Analyses | 07/14/2022 | Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive AnalysisAnalyses 07/14/2022 |
| https://sentinelinitiative.org/news-events/publications-presentations/new-onset-cancer-cases-fda-s-sentinel-system-large | New-Onset Cancer Cases in FDA’s Sentinel System: A Large Distributed System of US Electronic Healthcare Data | Publications and Presentations | 07/15/2022 | New-Onset Cancer Cases in FDA’s Sentinel System: A Large Distributed System of US Electronic Healthcare DataPublications and Presentations 07/15/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-sodium-glucose-co | Counts and Characteristics of Individuals with Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitor Use: A Descriptive Analysis | Analyses | 07/15/2022 | Counts and Characteristics of Individuals with Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitor Use: A Descriptive AnalysisAnalyses 07/15/2022 |
| https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/zimhi-naloxone | Assessment of ARIA Sufficiency: Zimhi (naloxone) | Sufficiency Assessments | 07/20/2022 | Assessment of ARIA Sufficiency: Zimhi (naloxone)Sufficiency Assessments 07/20/2022 |
| https://sentinelinitiative.org/news-events/publications-presentations/novel-methods-pregnancy-drug-safety-surveillance-fda | Novel Methods for Pregnancy Drug Safety Surveillance in the FDA Sentinel System | Publications and Presentations | 07/24/2022 | Novel Methods for Pregnancy Drug Safety Surveillance in the FDA Sentinel SystemPublications and Presentations 07/24/2022 |
| https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-obesity-drugs-descriptive-analysis | Utilization of Obesity Drugs: A Descriptive Analysis | Analyses | 08/05/2022 | Utilization of Obesity Drugs: A Descriptive AnalysisAnalyses 08/05/2022 |
| https://sentinelinitiative.org/studies/drugs/women-heart-failure | Women with Heart Failure & Pregnancy | Studies | 08/10/2022 | Women with Heart Failure & PregnancyStudies 08/10/2022 |
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/advancing-use-real-world-evidence-health-technology | Advancing the Use of Real-World Evidence for Health Technology Assessment – The NICE Real-World Evidence Framework | Sentinel Initiative Events | 08/11/2022 | Advancing the Use of Real-World Evidence for Health Technology Assessment – The NICE Real-World Evidence FrameworkSentinel Initiative Events 08/11/2022 |
| https://sentinelinitiative.org/news-events/publications-presentations/association-covid-19-vs-influenza-risk-arterial-and-venous | Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients | Publications and Presentations | 08/16/2022 | Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized PatientsPublications and Presentations 08/16/2022 |
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/38th-international-conference-pharmacoepidemiology-and | 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management | 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management08/24/2022 |
||
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/representing-and-utilizing-clinical-textual-data-real | Representing and Utilizing Clinical Textual Data for Real World Studies: An OHDSI Approach | Sentinel Initiative Events | Representing and Utilizing Clinical Textual Data for Real World Studies: An OHDSI ApproachSentinel Initiative Events 08/30/2022 |
|
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/deep-learning-electronic-health-records-research | Deep Learning on Electronic Health Records for Research in Pharmacoepidemiology: Examples From the Field of Oncology | Sentinel Initiative Events | Deep Learning on Electronic Health Records for Research in Pharmacoepidemiology: Examples From the Field of OncologySentinel Initiative Events 09/07/2022 |
|
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/machine-learning-high-dimensional-proxy-covariate | Machine Learning for High-dimensional Proxy Covariate Adjustment in Healthcare Database Studies: An Overview of the Current Literature | Sentinel Initiative Events | Machine Learning for High-dimensional Proxy Covariate Adjustment in Healthcare Database Studies: An Overview of the Current LiteratureSentinel Initiative Events 09/12/2022 |
|
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/overview-sentinel-s-publicly-available-analytics-tools | An Overview of Sentinel’s Publicly Available Analytics Tools | Sentinel Initiative Events | An Overview of Sentinel’s Publicly Available Analytics ToolsSentinel Initiative Events 09/14/2022 |
|
| https://sentinelinitiative.org/news-events/meetings-workshops-trainings/addressing-missing-data-comparative-effectiveness-research | Addressing Missing Data in Comparative Effectiveness Research Using EHR Data | Sentinel Initiative Events | Addressing Missing Data in Comparative Effectiveness Research Using EHR DataSentinel Initiative Events 09/26/2022 |